A randomized open label Phase III trial of afatinib versus erlotinib in patients with advanced squamous cell carcinoma of the lung as second line therapy following first line platinum based chemotherapy BI 1200 125 LUX Lung
Projeler > Desteklenmiş Diğer Projeler · 2012
Yazarlar: Tuncay GÖKSEL
2012-2013, Desteklenmiş Diğer Projeler, AR-GE Projesi, Tamamlandı